Vikas Sinha

Director

Vikas Sinha (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in VRNA. The largest single filing was $715K of SRRK (16,755 sh × $42.70, as filed), executed Jan 13.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.2M

shares × price, as filed

Last traded

Apr 16

Filed Apr 20

Median ADV $72.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

VRNA VRNA VRNA · 0 buys · 3 sells 3 filings SRRK

Scholar Rock Holding Corporation SRRK · 0 buys · 2 sells 2 filings

Recent filings

SRRKSALE Scholar Rock Holding Corporation View filing → $516K
10,410 sh × $49.57
Exec Apr 16
Filed Apr 20 · 5:30 PM ET SRRKSALE Scholar Rock Holding Corporation View filing → $715K
16,755 sh × $42.70
Exec Jan 13
Filed Jan 15 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $1.5M
160,000 sh × $9.39
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $134K
15,048 sh × $8.92
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $1.4M
160,000 sh across 2 lots
Exec Apr 29 2025
Filed May 22 2025 · 5:30 PM ET †